Letter to the Editor
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Aug 15, 2022; 14(8): 1594-1596
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1594
Exosomes: Promising biomarkers and targets for cancer
Zhen Fang, Yi-Xuan Ding, Fei Li
Zhen Fang, Yi-Xuan Ding, Fei Li, Department of General Surgery, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
Author contributions: Fang Z and Ding YX wrote the manuscript; Li F designed the study; and All authors have read and approve the final manuscript.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhen Fang, PhD, Academic Research, Surgeon, Department of General Surgery, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. ifang123@163.com
Received: February 17, 2022
Peer-review started: February 17, 2022
First decision: April 17, 2022
Revised: April 25, 2022
Accepted: July 19, 2022
Article in press: July 19, 2022
Published online: August 15, 2022
Processing time: 174 Days and 4.6 Hours
Core Tip

Core Tip: Exosomes have been shown to be major transmitters of cell-to-cell communication. Several advantageous features make exosomes effective therapeutic targets for cancer and ideal vehicles for drug delivery. This letter highlights the opportunities and challenges for clinical study and application of exosomes.